Bauke Anninga

Bauke joined M Ventures in 2019 and is currently a Principal in the Biotechnology team. Bauke is a board director or observer on NanoSyrinx, Pictor Labs, Synaffix, Immunitas Therapeutics and iOnctura. Before joining M Ventures, he was with Jefferies International in the Healthcare Investment Banking group in London (UK). During his time at Jefferies he advised on several financings and M&A transactions across the biotechnology, pharmaceutical and medical devices sectors.

Bauke has a PhD in Cancer Studies from King’s College London (UK) and an MSc in Technical Medicine from the University of Twente (The Netherlands).